Search
Now showing items 1-5 of 5
Client and provider perspectives of the efficiency and quality of care in the context of rapid scale-up of antiretroviral therapy
(Mary Ann Liebert, 2010)
Global scale-up of antiretroviral therapy (ART) has focused on clinical outcomes with little attention on its impact on existing health systems. In June–August 2008, we conducted a formative evaluation on ART scale-up and ...
Can response of a pruritic papular eruption to antiretroviral therapy be used as a clinical parameter to monitor virological outcome?
(Lippincott Williams & Wilkins, 2008)
Background: A pruritic papular eruption (PPE) is a common skin manifestation observed in 12–46% of persons with HIV infection living in tropical countries. Objective: To determine whether PPE responds to HAART and whether ...
Cause-Specific Mortality and the Contribution of Immune Reconstitution Inflammatory Syndrome in the First 3 Years after Antiretroviral Therapy Initiation in an Urban African Cohort
(Infectious Diseases Society of America, 2009)
Background. Although many studies have reported high early mortality among patients enrolled in antiretroviral therapy (ART) programs in sub-Saharan Africa—particularly among those individuals with advanced immunodeficiency— ...
Are the best antiretrovirals being used in Africa?
(Mediscript Limited, 2006)
No Abstract
Longitudinal patients’ cohorts for impactful research and HIV care at the Infectious Diseases Institute
(2022)
Introduction
Observational studies provide important evidence supporting the feasibility and effectiveness of health interventions. The 20-year-old Infectious Diseases Institute (IDI) established to respond to infectious ...